Heidelberg, Germany 04.08.2021 –BioLabs Global, a network of shared lab facilities for high-potential life-science start-ups located in key biotech innovation clusters, today announces that Eli Lilly and Company has become a Gold Sponsor of BioLabs’ latest European location in Heidelberg, Germany.
BioLabs is working closely with BioRN, the leading non-profit membership network supporting the Life Science Cluster in the Rhine-Neckar region, to adapt BioLabs US co-working model to the German research and biotech environment. Heidelberg belongs to the leading Life Science Clusters in South Germany, which is the birthplace of companies such as BioNTech, Cellzome, ImClone, Phenex and Ganymed. The new Heidelberg site will offer first-class, fully outfitted wet laboratories, furnished office spaces, and access to premium scientific equipment for early-stage life-science companies. BioLabs Heidelberg will celebrate its Groundbreaking event on August 16 in Heidelberg.
Lilly has been a constant and key sponsor of BioLabs at multiple US sites since 2017. With their new sponsorship of BioLabs-Heidelberg, Lilly is renewing their commitment to continue to support BioLabs and the development of innovative entrepreneurial ecosystems in multiple geographies. As an integral part of their three-year sponsorship, Lilly will offer guidance and provide expertise to young entrepreneurs. In particular, leaders from Lilly’s European business development function are well-placed to engage with emerging local companies on the ground.
“Lilly joining Biolabs-Heidelberg as the third major sponsor further validates the need for the co-working concept in Heidelberg. It demonstrates Lilly’s commitment to the development of the Rhine- Neckar innovation hub and lays the foundation for longstanding partnerships, connecting the region’s growing biotech start-up ecosystem to the world-wide biotech community,” said Julia Schaft, managing director at BioRN.
“We are excited to be partnering with Lilly again as we expand BioLabs to Germany. Lilly has been an excellent mentor to many of our start-up companies and together we will build on the strong academic environment in Heidelberg to develop a center for innovation and entrepreneurship.” said Johannes Fruehauf, M.D. Ph.D., President and CEO, BioLabs.
“Heidelberg is one of the world’s leading centers of excellence in Life Sciences. Lilly is proud to support BioLabs in Heidelberg strengthening this emerging European biotech hub and helping to convert scientific innovation into future therapies for patients in need” said Petra Jumpers, president and general manager of Lilly Germany.
“At Lilly we recognize that the most promising innovation often originates in regional hubs like Heidelberg, where academics and entrepreneurs come together to advance science from discovery to development. We are proud to sponsor this shared lab facility, which will enable a new wave of promising life-sciences start-ups” said Kenneth Custer, vice president, head of corporate business development, Lilly.
BioRN is the science and industry cluster of the Rhine-Main-Neckar region around Heidelberg, one of Germany’s strongest biotech hubs. It is a non-profit network fostering health innovations and serving its members by creating a rich translational ecosystem as well as promoting, representing, and connecting the regional innovation stakeholders. Our vision is to develop the region into a world-leading life science cluster attracting international investments and top global talent.
BioRN has more than 100 institutional members, including the top academic and research institutions, 8 global pharmaceutical companies, a large range of small and medium-sized enterprises bolstering the life science ecosystem as well as local government organizations and interest groups. www.biorn.org
BioLabs is a membership-based network of shared laboratory facilities located in key geographies with proven biotech innovation clusters. BioLabs offers beautifully designed coworking environments that pair fully equipped and supported lab, office, and event spaces with relevant programming and unparalleled access to capital and industry partners. These fertile, supportive ecosystems allow young companies to shift their focus from start-up operations to experimentation and innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single lab bench and scale-up as they grow. The expanding BioLabs and Affiliates US network of labs now comprises sites in Boston and Cambridge, Massachusetts; Durham, North Carolina; San Diego and Los Angeles, California; New York City; Princeton, New Jersey; Philadelphia, Pennsylvania; Dallas, TX (coming Fall 2021) and is developing additional domestic and international sites. www.biolabs.io
VP Business Development
139 Main St, suite 401
Cambridge, MA 02142
Dr. Annalisa Zuccotti
BioRN Cluster Management GmbH
Communication & Events Lead
P: 49 6221 4305-113